NAFTA Board Tosses $520M Apotex Case Over FDA Import Ban
The North American Free Trade Agreement's arbitration tribunal on Tuesday rejected a $520 million Canadian pharmaceutical company's complaint that the U.S. Food and Drug Administration violated the treaty by forbidding the...To view the full article, register now.
Already a subscriber? Click here to view full article